HNB
AXSM icon

Huntington National Bank’s Axsome Therapeutics AXSM Stock Holding History

Huntington National Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.6K Buy
270
+5
+2% +$864 ﹤0.01% 1374
2025
Q4 		$48.4K Buy
265
+37
+16% +$5.17K ﹤0.01% 1257
2025
Q3 		$27.7K Buy
228
+29
+15% +$3.27K ﹤0.01% 1481
2025
Q2 		$20.8K Buy
199
+14
+8% +$1.48K ﹤0.01% 1558
2025
Q1 		$21.6K Sell
185
-29
-14% -$3.3K ﹤0.01% 1491
2024
Q4 		$18.1K Sell
214
-1
-0.5% -$92 ﹤0.01% 1573
2024
Q3 		$19.3K Buy
215
+2
+0.9% +$175 ﹤0.01% 1521
2024
Q2 		$17.1K Sell
213
-123
-37% -$9.11K ﹤0.01% 1508
2024
Q1 		$26.8K Sell
336
-14
-4% -$1.18K ﹤0.01% 1375
2023
Q4 		$27.9K Buy
350
+2
+0.6% +$134 ﹤0.01% 1318
2023
Q3 		$24.3K Sell
348
-13
-4% -$972 ﹤0.01% 1296
2023
Q2 		$25.9K Buy
361
+45
+14% +$3.32K ﹤0.01% 1279
2023
Q1 		$19.5K Sell
316
-51
-14% -$3.35K ﹤0.01% 1323
2022
Q4 		$28.3K Buy
367
+36
+11% +$2.15K ﹤0.01% 1175
2022
Q3 		$14K Hold
331
– – ﹤0.01% 1419
2022
Q2 		$13K Hold
331
– – ﹤0.01% 1477
2022
Q1 		$14K Sell
331
-1
-0.3% -$31 ﹤0.01% 1476
2021
Q4 		$13K Sell
332
-75
-18% -$2.76K ﹤0.01% 1500
2021
Q3 		$13K Buy
407
+70
+21% +$2.73K ﹤0.01% 1366
2021
Q2 		$23K Buy
337
+63
+23% +$3.78K ﹤0.01% 1178
2021
Q1 		$16K Buy
+274
New +$19.3K ﹤0.01% 1202
2020
Q1 		– Sell
-500
Closed -$52K – 1538
2019
Q4 		$52K Buy
+500
New +$20.2K ﹤0.01% 925

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Huntington National Bank's AXSM Position: Q1 2026 in Review

Huntington National Bank increased its Axsome Therapeutics (AXSM) stake by 1.9% in Q1 2026, buying an estimated $864 and bringing the position to 270 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Huntington National Bank first reported a position in AXSM in Q4 2019 and has held it in 22 quarters since. The position peaked at $52K in Q4 2019. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Huntington National Bank held 270 shares of Axsome Therapeutics worth $45.6K as of Q1 2026.
  • Huntington National Bank bought 5 Axsome Therapeutics shares in Q1 2026, an estimated $864.
  • Axsome Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1374 holding.
  • Huntington National Bank first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 22 quarters since.
  • Huntington National Bank's Axsome Therapeutics position peaked at $52K in Q4 2019.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.